| Product Code: ETC10765614 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
The import shipments of pemetrexed to Ireland saw significant growth in 2024, with top exporting countries being Germany, UK, USA, Canada, and other areas. The market concentration, as measured by the HHI, shifted from moderate to high in 2024, indicating increased dominance by key players. The compound annual growth rate (CAGR) from 2020 to 2024 was impressive at 23.25%, with a notable growth rate of 68.68% from 2023 to 2024. This data suggests a thriving market for pemetrexed in Ireland with strong potential for continued growth and competition among key exporters.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Pemetrexed Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Pemetrexed Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Pemetrexed Market - Industry Life Cycle |
3.4 Ireland Pemetrexed Market - Porter's Five Forces |
3.5 Ireland Pemetrexed Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Ireland Pemetrexed Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.7 Ireland Pemetrexed Market Revenues & Volume Share, By Combination Therapy, 2021 & 2031F |
3.8 Ireland Pemetrexed Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Ireland Pemetrexed Market Revenues & Volume Share, By Administration Route, 2021 & 2031F |
4 Ireland Pemetrexed Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Ireland Pemetrexed Market Trends |
6 Ireland Pemetrexed Market, By Types |
6.1 Ireland Pemetrexed Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Ireland Pemetrexed Market Revenues & Volume, By Indication, 2021 - 2031F |
6.1.3 Ireland Pemetrexed Market Revenues & Volume, By Non-Small Cell Lung Cancer, 2021 - 2031F |
6.1.4 Ireland Pemetrexed Market Revenues & Volume, By Mesothelioma, 2021 - 2031F |
6.1.5 Ireland Pemetrexed Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.1.6 Ireland Pemetrexed Market Revenues & Volume, By Colorectal Cancer, 2021 - 2031F |
6.1.7 Ireland Pemetrexed Market Revenues & Volume, By Pancreatic Cancer, 2021 - 2031F |
6.2 Ireland Pemetrexed Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 Ireland Pemetrexed Market Revenues & Volume, By Antifolate, 2021 - 2031F |
6.2.3 Ireland Pemetrexed Market Revenues & Volume, By DNA Synthesis Inhibition, 2021 - 2031F |
6.2.4 Ireland Pemetrexed Market Revenues & Volume, By Enzyme Targeting, 2021 - 2031F |
6.2.5 Ireland Pemetrexed Market Revenues & Volume, By Cell Growth Suppression, 2021 - 2031F |
6.2.6 Ireland Pemetrexed Market Revenues & Volume, By Purine Synthesis Blockade, 2021 - 2031F |
6.3 Ireland Pemetrexed Market, By Combination Therapy |
6.3.1 Overview and Analysis |
6.3.2 Ireland Pemetrexed Market Revenues & Volume, By Platinum-Based Chemotherapy, 2021 - 2031F |
6.3.3 Ireland Pemetrexed Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.3.4 Ireland Pemetrexed Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.3.5 Ireland Pemetrexed Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
6.3.6 Ireland Pemetrexed Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.4 Ireland Pemetrexed Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Ireland Pemetrexed Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Ireland Pemetrexed Market Revenues & Volume, By Oncology Clinics, 2021 - 2031F |
6.4.4 Ireland Pemetrexed Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.5 Ireland Pemetrexed Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.6 Ireland Pemetrexed Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.5 Ireland Pemetrexed Market, By Administration Route |
6.5.1 Overview and Analysis |
6.5.2 Ireland Pemetrexed Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.5.3 Ireland Pemetrexed Market Revenues & Volume, By Injection, 2021 - 2031F |
6.5.4 Ireland Pemetrexed Market Revenues & Volume, By IV Infusion, 2021 - 2031F |
6.5.5 Ireland Pemetrexed Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.5.6 Ireland Pemetrexed Market Revenues & Volume, By Hospital Pharmacy, 2021 - 2031F |
7 Ireland Pemetrexed Market Import-Export Trade Statistics |
7.1 Ireland Pemetrexed Market Export to Major Countries |
7.2 Ireland Pemetrexed Market Imports from Major Countries |
8 Ireland Pemetrexed Market Key Performance Indicators |
9 Ireland Pemetrexed Market - Opportunity Assessment |
9.1 Ireland Pemetrexed Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Ireland Pemetrexed Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.3 Ireland Pemetrexed Market Opportunity Assessment, By Combination Therapy, 2021 & 2031F |
9.4 Ireland Pemetrexed Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Ireland Pemetrexed Market Opportunity Assessment, By Administration Route, 2021 & 2031F |
10 Ireland Pemetrexed Market - Competitive Landscape |
10.1 Ireland Pemetrexed Market Revenue Share, By Companies, 2024 |
10.2 Ireland Pemetrexed Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here